Recursion Pharmaceuticals (RXRX.MX) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-10.88
-9.46
-8.04
-6.62

Details

Expected EPS
-6.6155597589
Actual EPS
-7.676552999999998
Surprise EPS
-1.06
Surprise Percent
+16.04%

Description

Recursion Pharmaceuticals (RXRX.MX) has reported earnings of -7.676552999999998 per share for Q3 2025.

0 Comments

Share your thoughts